LY3316531

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LY3316531, covering 2023-09-21 to 2024-08-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3316531 in Healthy Participants [Phase 1]